These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37134145)

  • 1. Ezh2 knockout in B cells impairs plasmablast differentiation and ameliorates lupus-like disease in MRL/lpr mice: comment on the article by Zheng et al.
    Huang AF; Xu WD
    Arthritis Rheumatol; 2023 Nov; 75(11):2064-2065. PubMed ID: 37134145
    [No Abstract]   [Full Text] [Related]  

  • 2. Ezh2 Knockout in B Cells Impairs Plasmablast Differentiation and Ameliorates Lupus-like Disease in MRL/lpr Mice.
    Zheng X; Dozmorov MG; Strohlein CE; Bastacky S; Sawalha AH
    Arthritis Rheumatol; 2023 Aug; 75(8):1395-1406. PubMed ID: 36897808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
    Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
    Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon regulatory factor-5 deficiency ameliorates disease severity in the MRL/lpr mouse model of lupus in the absence of a mutation in DOCK2.
    Yasuda K; Watkins AA; Kochar GS; Wilson GE; Laskow B; Richez C; Bonegio RG; Rifkin IR
    PLoS One; 2014; 9(7):e103478. PubMed ID: 25076492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
    Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K
    J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
    White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
    Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis.
    Kunishita Y; Yoshimi R; Kamiyama R; Kishimoto D; Yoshida K; Hashimoto E; Komiya T; Sakurai N; Sugiyama Y; Kirino Y; Ozato K; Nakajima H
    Front Immunol; 2020; 11():98. PubMed ID: 32117252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice.
    Bökers S; Urbat A; Daniel C; Amann K; Smith KG; Espéli M; Nitschke L
    J Immunol; 2014 Apr; 192(7):2994-3002. PubMed ID: 24600033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.
    Moritoki M; Kadowaki T; Niki T; Nakano D; Soma G; Mori H; Kobara H; Masaki T; Kohno M; Hirashima M
    PLoS One; 2013; 8(4):e60807. PubMed ID: 23585851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central and multiple roles of B cells in lupus pathogenesis.
    Chan OT; Madaio MP; Shlomchik MJ
    Immunol Rev; 1999 Jun; 169():107-21. PubMed ID: 10450512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
    Zhang X; Wang G; Bi Y; Jiang Z; Wang X
    Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
    Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
    Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
    Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
    Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
    J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells.
    Mandik-Nayak L; Seo SJ; Sokol C; Potts KM; Bui A; Erikson J
    J Exp Med; 1999 Jun; 189(11):1799-814. PubMed ID: 10359584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ANX A1 Antibody Therapy in MRL/lpr Murine Model of Systemic Lupus Erythematosus.
    Bradyanova S; Mihaylova N; Chipinski P; Manassiev Y; Herbáth M; Kyurkchiev D; Prechl J; Tchorbanov AI
    Arch Immunol Ther Exp (Warsz); 2021 Jul; 69(1):19. PubMed ID: 34322760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
    J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutaminase 1 Inhibition Reduces Glycolysis and Ameliorates Lupus-like Disease in MRL/lpr Mice and Experimental Autoimmune Encephalomyelitis.
    Kono M; Yoshida N; Maeda K; Suárez-Fueyo A; Kyttaris VC; Tsokos GC
    Arthritis Rheumatol; 2019 Nov; 71(11):1869-1878. PubMed ID: 31233276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice.
    Reilly CM; Gilkeson GS
    Immunol Res; 2002; 25(2):143-53. PubMed ID: 11999168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
    Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE
    J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.